Prelude Therapeutics's total assets for Q2 2025 were $114.92M, a decrease of -18.65% from the previous quarter. PRLD total liabilities were $39.08M for the fiscal quarter, a 2.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.